Enzyre Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series B
  • (In Progress)

  • Latest Deal Amount
  • $5.81M

  • Investors
  • 8

Enzyre General Information

Description

Developer of a diagnostic technology designed to perform laboratory testing at the point of care for monitoring coagulation. The company offers a chemiluminescence-based platform with a handheld processor, microfluidic cartridges, and mobile application integration, enabling patients with bleeding disorders and healthcare professionals to monitor coagulation status and share test data with clinicians for therapy management.

Contact Information

Website
www.enzyre.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Transistorweg 5
  • 6534 AT Nijmegen
  • Netherlands
+31 024
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Transistorweg 5
  • 6534 AT Nijmegen
  • Netherlands
+31 024

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzyre Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC (Series B) $5.81M In Progress Startup
7. Grant Completed Startup
6. Later Stage VC (Series A) 02-Nov-2022 Completed Startup
5. Later Stage VC 04-Mar-2021 Completed Startup
4. Debt - General 27-Jul-2020 Completed Startup
3. Later Stage VC 12-Dec-2019 Cancelled Startup
2. Grant 30-Apr-2019 $2.25M $1.12M Completed Startup
1. Seed Round 30-Apr-2019 $1.12M $1.12M Completed Startup
To view Enzyre’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Enzyre Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a diagnostic technology designed to perform laboratory testing at the point of care for monitoring coagulat
Diagnostic Equipment
Nijmegen, Netherlands
9 As of 2026

Hudson, OH
 

Santa Clara, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enzyre Competitors (5)

One of Enzyre’s 5 competitors is ClotChip, a Venture Capital-Backed company based in Hudson, OH.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ClotChip Venture Capital-Backed Hudson, OH
Micropoint Formerly VC-backed Santa Clara, CA
HemoSonics Formerly VC-backed Durham, NC
rhealth Angel-Backed Bedford, MA
CoaguSense Venture Capital-Backed Fremont, CA
You’re viewing 5 of 5 competitors. Get the full list »

Enzyre Patents

Enzyre Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025262269-A1 Monitoring of reversal agents for anticoagulants Pending 21-Jun-2024
EP-4795054-A1 Caged luciferins and related compounds and methods Pending 16-Oct-2023
WO-2025082999-A1 Caged luciferins and related compounds and methods Inactive 16-Oct-2023
EP-4713335-A1 Compounds and methods for high purity chemiluminescent substrates Pending 17-May-2023
WO-2024236166-A1 Compounds and methods for high purity chemiluminescent substrates Inactive 17-May-2023 C07K1/04
To view Enzyre’s complete patent history, request access »

Enzyre Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enzyre Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Demcon Corporation Minority
i&i Biotech Fund Venture Capital Minority
Oost NL Venture Capital Minority
Rijksdienst voor Ondernemend Nederland Government Minority
Takeda Ventures Corporate Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Enzyre Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Enzyre Manufacturing Nijmegen, Netherlands 2022

Enzyre FAQs

  • When was Enzyre founded?

    Enzyre was founded in 2016.

  • Where is Enzyre headquartered?

    Enzyre is headquartered in Nijmegen, Netherlands.

  • What is the size of Enzyre?

    Enzyre has 9 total employees.

  • What industry is Enzyre in?

    Enzyre’s primary industry is Diagnostic Equipment.

  • Is Enzyre a private or public company?

    Enzyre is a Private company.

  • What is Enzyre’s current revenue?

    The current revenue for Enzyre is .

  • How much funding has Enzyre raised over time?

    Enzyre has raised $14.5M.

  • Who are Enzyre’s investors?

    Demcon, i&i Biotech Fund, Oost NL, Rijksdienst voor Ondernemend Nederland, and Takeda Ventures are 5 of 8 investors who have invested in Enzyre.

  • Who are Enzyre’s competitors?

    ClotChip, Micropoint, HemoSonics, rhealth, and CoaguSense are competitors of Enzyre.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process